FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213536491> ?p ?o ?g. }

• W3213536491 endingPage "472" @default.
• W3213536491 startingPage "460" @default.
• W3213536491 abstract "The optimal timing for administering high-dose methotrexate (HDMTX) when combined with (R)CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone, with/without rituximab) is unclear. Recent data showed that the administration of prophylactic HDMTX before day 10 of R- CHOP may lead to fewer treatment delays. Herein, we report our experience with HDMTX administered on day 1 of (R)CHOP in patients with aggressive non-Hodgkin lymphoma (NHL). We identified 140 patients treated with ≥1 cycle of HDMTX combined with (R)CHOP for prophylaxis against (n = 84) or treatment of (n = 56) central nervous system (CNS) involvement. Overall, (R)CHOP treatment delays ≥7 days (4% of cycles, 13% of patients), doxorubicin, and/or cyclophosphamide dose reductions (1% of cycles, 6% of patients) or (R)CHOP discontinuations due to toxicity (4% of patients) were uncommon. Neutropenic fever (NF) occurred in 7% of cycles and 24% of patients and was more common during HDMTX-containing cycles. Acute kidney injury (AKI) occurred in 19% of cycles but was mostly grade ≤2. Grade ≥3 hepatotoxicity and mucositis were uncommon (each 2% of cycles). In the prophylaxis cohort, the rates of NF and grade ≥2 AKI were lower in patients who initiated HDMTX with cycle 2 or later (11% vs 30%, P = .03 and 16% vs 39%, P = .03, respectively). Our data show that HDMTX administration on day 1 of (R)CHOP may improve the deliverability of (R)CHOP and the overall safety of the regimen compared with historical data of HDMTX administration on day 10 or later of R-CHOP. Delaying prophylactic HDMTX beyond cycle 1 of (R)CHOP may reduce the risk of NF and AKI." @default.
• W3213536491 created "2021-11-22" @default.
• W3213536491 creator A5003367392 @default.
• W3213536491 creator A5011175042 @default.
• W3213536491 creator A5012846289 @default.
• W3213536491 creator A5017559837 @default.
• W3213536491 creator A5024389256 @default.
• W3213536491 creator A5046741008 @default.
• W3213536491 creator A5051862003 @default.
• W3213536491 creator A5054730003 @default.
• W3213536491 creator A5063133761 @default.
• W3213536491 creator A5082021894 @default.
• W3213536491 creator A5085565650 @default.
• W3213536491 creator A5088169139 @default.
• W3213536491 date "2022-01-17" @default.
• W3213536491 modified "2023-10-14" @default.
• W3213536491 title "Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas" @default.
• W3213536491 cites W1828514487 @default.
• W3213536491 cites W1949042228 @default.
• W3213536491 cites W1973121555 @default.
• W3213536491 cites W1985486670 @default.
• W3213536491 cites W1993941594 @default.
• W3213536491 cites W1995939575 @default.
• W3213536491 cites W2003285045 @default.
• W3213536491 cites W2011923772 @default.
• W3213536491 cites W2070894157 @default.
• W3213536491 cites W2071364749 @default.
• W3213536491 cites W2075456403 @default.
• W3213536491 cites W2089242301 @default.
• W3213536491 cites W2096047333 @default.
• W3213536491 cites W2155495849 @default.
• W3213536491 cites W2157862701 @default.
• W3213536491 cites W2161965680 @default.
• W3213536491 cites W2226282127 @default.
• W3213536491 cites W2273792084 @default.
• W3213536491 cites W2280269954 @default.
• W3213536491 cites W2414855633 @default.
• W3213536491 cites W2462981464 @default.
• W3213536491 cites W2514966489 @default.
• W3213536491 cites W2563794893 @default.
• W3213536491 cites W2586303434 @default.
• W3213536491 cites W2625414910 @default.
• W3213536491 cites W2734666624 @default.
• W3213536491 cites W2794015106 @default.
• W3213536491 cites W2914421858 @default.
• W3213536491 cites W2919015634 @default.
• W3213536491 cites W2923453543 @default.
• W3213536491 cites W2927138762 @default.
• W3213536491 cites W2949002175 @default.
• W3213536491 cites W2953028746 @default.
• W3213536491 cites W2955993953 @default.
• W3213536491 cites W3026055638 @default.
• W3213536491 cites W3032984305 @default.
• W3213536491 cites W3037127281 @default.
• W3213536491 cites W3047361396 @default.
• W3213536491 cites W3097597879 @default.
• W3213536491 cites W3122253409 @default.
• W3213536491 cites W3151335737 @default.
• W3213536491 cites W3154920207 @default.
• W3213536491 cites W3158033047 @default.
• W3213536491 cites W3164159595 @default.
• W3213536491 cites W3201743266 @default.
• W3213536491 doi "https://doi.org/10.1182/bloodadvances.2021005999" @default.
• W3213536491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34788387" @default.
• W3213536491 hasPublicationYear "2022" @default.
• W3213536491 type Work @default.
• W3213536491 sameAs 3213536491 @default.
• W3213536491 citedByCount "6" @default.
• W3213536491 countsByYear W32135364912022 @default.
• W3213536491 countsByYear W32135364912023 @default.
• W3213536491 crossrefType "journal-article" @default.
• W3213536491 hasAuthorship W3213536491A5003367392 @default.
• W3213536491 hasAuthorship W3213536491A5011175042 @default.
• W3213536491 hasAuthorship W3213536491A5012846289 @default.
• W3213536491 hasAuthorship W3213536491A5017559837 @default.
• W3213536491 hasAuthorship W3213536491A5024389256 @default.
• W3213536491 hasAuthorship W3213536491A5046741008 @default.
• W3213536491 hasAuthorship W3213536491A5051862003 @default.
• W3213536491 hasAuthorship W3213536491A5054730003 @default.
• W3213536491 hasAuthorship W3213536491A5063133761 @default.
• W3213536491 hasAuthorship W3213536491A5082021894 @default.
• W3213536491 hasAuthorship W3213536491A5085565650 @default.
• W3213536491 hasAuthorship W3213536491A5088169139 @default.
• W3213536491 hasBestOaLocation W32135364911 @default.
• W3213536491 hasConcept C126322002 @default.
• W3213536491 hasConcept C141071460 @default.
• W3213536491 hasConcept C2776694085 @default.
• W3213536491 hasConcept C2776755627 @default.
• W3213536491 hasConcept C2778720950 @default.
• W3213536491 hasConcept C2779338263 @default.
• W3213536491 hasConcept C2779429289 @default.
• W3213536491 hasConcept C2779725641 @default.
• W3213536491 hasConcept C2781059491 @default.
• W3213536491 hasConcept C2781303535 @default.
• W3213536491 hasConcept C71924100 @default.
• W3213536491 hasConcept C90924648 @default.
• W3213536491 hasConceptScore W3213536491C126322002 @default.
• W3213536491 hasConceptScore W3213536491C141071460 @default.

• next